Skip to main content
. 2015 Sep 4;5:13617. doi: 10.1038/srep13617

Table 1. Clinical characteristics of the hospitalized patients from the two outbreaks#.

Characteristic Value*
Xiangyang outbreak (n = 321) Jingmen outbreak (n = 42)
Symptoms or signs
Fever
 Any-no. (%) 319 (99.4) 42 (100.0)
Subgroup-no. (%)
 37.3–38.0 °C 10 (3.1) 0
 38.1–39.0 °C 131 (40.8) 20 (47.6)
 >39.0 °C 178 (55.5) 22 (52.4)
Maximal temperature (°C), mean 39.2 ± 0.6 39.4 ± 0.7
Duration of fever, median (range), days 4.0 (1–20) 4.0 (2–11)
Cough 304 (94.7) 40 (95.2)
Throat congestion 296 (92.2) 36 (85.7)
Sore throat 246 (76.6) 32 (76.2)
Sputum production -no./total no. (%) 234/321 (72.9) 34/42 (81.0)
 Yellow sputum 145/234 (62.0) 24/34 (70.6)
 White sputum 89/234 (38.0) 10/34 (29.4)
 Blood-streaked sputum 28/234 (12.0) 6/34 (17.6)
Swelling of tonsils 211 (65.7) 24 (57.1)
Fatigue 139 (43.3) 21 (50.0)
Pharyngeal lymphoid follicular hyperplasia 126 (39.3) 15 (35.7)
Purulent exudate on the tonsil 102 (31.8) 12 (28.6)
Rhinorrhea 79 (24.6) 9 (21.4)
Myalgia 76 (23.7) 8 (19.0)
Headache 64 (19.9) 8 (19.0)
Dizziness 61 (19.0) 5 (11.9)
Shortness of breath 54 (16.8) 8 (19.0)
Chest pain 51 (15.9) 9 (21.4)
Diarrhea 30 (9.3) 5 (11.9)
Nasal congestion 29 (9.0) 2 (4.8)
Chill 23 (7.2) 2 (4.8)
Enlargement of lymph nodes 20 (6.2) 4 (9.5)
Abdominal pain 19 (5.9) 3 (7.1)
Bronchitis 18 (5.6) 1 (2.4)
Nausea 12 (3.7) 5 (11.9)
Vomiting 8 (2.5) 1 (2.4)
Palpitation 3 (0.9) 1 (2.4)
Submandibular lymphadenitis 3 (0.9) 0
Tinnitus, earache 3 (0.9) 0
Skin rash 2 (0.6) 1 (2.4)
Convulsion, coma 2 (0.6) 0
Testicular pain 2 (0.6) 0
Clinical outcome
Hospitalization, no./total no. (%) 321/858 (37.4) 42/88 (47.7)
 Time from illness onset to hospitalization, median (range), days 3.0 (1–36) 3.0 (1–7)
 Duration of hospitalization, median (range), days 10.0 (6–25) 9.0 (7–25)
Pneumonia, no./total no. (%) 108/321 (36.2) 16/42 (38.1)
 Admission to an intensive care unit 37/108 (34.3) 4/16 (25.0)
 Heart injury 14/108 (13.0) 2/16 (12.5)
 Liver injury 11/108 (10.2) 3/16 (18.8)
 Gallbladder injury 3/108 (2.8) 1/16 (6.3)
 Meningitis irritation 2/108 (1.9) 0
 Secondary infections 10/108 (9.3) 2/16 (12.5)

#In this study 256 patients were confirmed as HAdV-7 positive infections among the 321 hospitalized patients by PCR and viral culture.

*In this study continuous variables were summarized as means (±SD) or medians (range).